Biology Reference
In-Depth Information
Fig. 15.1
In fl uence of natural
C
.
Bovis
and its substitutes on cardiac fibroblast viability. Cells
were incubated for 1 h with medium containing 0.25 mg/ml sample extracts. Values are expressed
as percent of control, in which the control cells were untreated. Data represent means ± S.E.
obtained from 15 to 29 samples from triplicate experiments. **
p
< 0.01 and *
p
< 0.05 compared
with control
15.3
Results and Discussion
15.3.1
The Biological Effects of Natural C . Bovis and Its
Substitutes on the Morphology of Cultured Fibroblasts
C
.
Bovis
is a common animal-derived therapeutic preparation often used as a cardio-
tonic, an antipyretic, an antispasmodic, an antidote, and a child sedative. As we
reported previously, of the 230 cardioactive OTC drugs, 228 (98.7%) contain
C
.
Bovis
in Japan (Takahashi et al.
2008
). In order to ascertain the biological differ-
ences of natural
C
.
Bovis
from its substitutes, we investigated their effects on cultured
cardiac fibroblasts using the MTS assay. As shown in Fig.
15.1
, although 0.25 mg/ml
of natural
C
.
Bovis
(Aus-1) did not affect fibroblast viability, substitutes (Art-1, Cul-1,
Cul-2) decreased cell viability approximately 10% after 1-h incubation.
15.3.2
The Organic Composition of Natural C . Bovis
and Its Substitutes
In order to investigate differences in organic composition between
C
.
Bovis
and its
substitutes, bile acids, such as cholic acid, taurocholic acid, and deoxycholic acid,
were measured. Although cholic acid accounts for less than 40% of bile acid con-
tent in natural
C
.
Bovis
samples (Aus-1, Aus-2, Brazil, Mexico, Kenya, and China),
Search WWH ::
Custom Search